摘要
背景:抗肿瘤化疗药物领域的研究寻求一个关键问题,即肿瘤细胞的药物选择性。在过去的20年里,一组蛋白质作为癌症化疗药物吸引了科学的兴趣,因为它们能够在不损害正常细胞的同时,特异性地杀死癌细胞。这些蛋白质之一是凋亡素。方法:对近年来有关凋亡素诱导细胞死亡机制的文献进行综述。将这种药物运送到肿瘤细胞是一个挑战,因为它会自发地形成可溶性的非共价聚集体。这使得我们在这篇综述中包括了不同的方法来获得凋亡素进入癌细胞的最大效率。结果:本文综述了凋亡素诱导肿瘤细胞选择性凋亡而使正常细胞不受损伤的机制。着重阐述了该蛋白诱导的凋亡机制与其功能结构的关系。凋亡素被描述为一种内在无序的蛋白质,它解释了它与多个伙伴相互作用并影响细胞内多种通路的能力。凋亡素诱导的不同伙伴和途径的特征已开始揭示凋亡素肿瘤选择性细胞毒性的分子基础。结论:本研究证实了凋亡素作为一种具有潜在安全性的抗肿瘤药物的应用前景。还需要进行研究,以找到一种有效的方法,将凋亡素用于临床。
关键词: 凋亡素,肿瘤,病毒蛋白,DNA损伤反应,凋亡,抗肿瘤药物。
Current Medicinal Chemistry
Title:Apoptin, A Versatile Protein with Selective Antitumor Activity
Volume: 25 Issue: 30
关键词: 凋亡素,肿瘤,病毒蛋白,DNA损伤反应,凋亡,抗肿瘤药物。
摘要: Background: Research in the field of antitumor chemotherapeutics pursues a key issue, drug selectivity for cancer cells. In the last 20 years, a group of proteins has attracted scientific interest as cancer chemotherapeutics due to their ability to specifically kill cancer cells while leaving normal cells undamaged. One of these proteins is apoptin.
Methods: In this study, the recent available literature regarding cell death mechanisms induced by apoptin has been reviewed. Delivering this drug to tumor cells is a challenge because it spontaneously forms soluble non-covalent aggregates. This led us to include in this review the different approaches for obtaining the maximum efficiency of apoptin entry to cancer cells.
Results: This review provides an up-to-date summary of the mechanisms by which apoptin induces selective apoptosis in tumor cells while leaving normal cells undamaged. It highlights the relationship between the apoptosis mechanism induced by this protein and its functional motifs. Apoptin has been described as an intrinsically disordered protein, which explains its ability to interact with multiple partners and affect multiple pathways inside the cell. Characterization of the different partners and pathways induced by apoptin has begun to shed light on the molecular basis of apoptin’s tumor-selective cytotoxicity.
Conclusion: The findings confirm the interest in apoptin as a potentially safe antitumor drug. Research still needed to be conducted to find an effective way to deliver apoptin for use in clinics.
Export Options
About this article
Cite this article as:
Apoptin, A Versatile Protein with Selective Antitumor Activity, Current Medicinal Chemistry 2018; 25 (30) . https://dx.doi.org/10.2174/0929867325666180309112023
DOI https://dx.doi.org/10.2174/0929867325666180309112023 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements